C
Christina A. Muzny
Researcher at University of Alabama at Birmingham
Publications - 128
Citations - 2833
Christina A. Muzny is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Medicine & Bacterial vaginosis. The author has an hindex of 21, co-authored 95 publications receiving 1472 citations. Previous affiliations of Christina A. Muzny include University of Alabama & University of Mississippi Medical Center.
Papers
More filters
Journal ArticleDOI
Sexually Transmitted Infections Treatment Guidelines,2021
Kimberly A. Workowski,Laura H. Bachmann,Philip A. Chan,Christine Johnston,Christina A. Muzny,Ina U. Park,Hilary Reno,Jonathan M. Zenilman,Gail Bolan +8 more
TL;DR: These guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019.
Journal ArticleDOI
Role of Gardnerella vaginalis in the Pathogenesis of Bacterial Vaginosis: A Conceptual Model
TL;DR: This model suggests that BV is initiated by the sexual transmission of Gardnerella vaginalis, which has the appropriate virulence factors to adhere to host epithelium, create a biofilm community, and successfully compete with lactobacilli for dominance in the vaginal environment.
Journal ArticleDOI
An Updated Conceptual Model on the Pathogenesis of Bacterial Vaginosis.
Christina A. Muzny,Christopher M. Taylor,W. Edward Swords,Ashutosh Tamhane,Debasish Chattopadhyay,Nuno Cerca,Jane R. Schwebke +6 more
TL;DR: An updated conceptual model for the pathogenesis of BV is presented that centers on the roles of virulent strains of G. vaginalis, as well as Prevotella bivia and Atopobium vaginae.
Journal ArticleDOI
Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options
TL;DR: D diagnosis of mucormycosis is typically difficult to make based on imaging studies, sputum culture, bronchoalveolar lavage culture, or needle aspirate, and posaconazole and isavuconazole are best reserved for de-escalation, refractory cases, or patients intolerant to amphotericin B.
Journal ArticleDOI
Biofilms: An Underappreciated Mechanism of Treatment Failure and Recurrence in Vaginal Infections.
TL;DR: The purpose of this review is to discuss the impact of biofilms on the management and treatment of BV and recurrent VVC and highlight the need for additional research and development of novel therapeutics targeting pathogenic vaginalBiofilms.